Certified Intellectual Property Rights Lawyer

The TRIPS Agreement (Trade-Related Aspects of Intellectual Property Rights) was signed in 1994 as part of the Marrakesh Agreement establishing the WTO. It came into effect on January 1, 1995.

WIPO is headquartered in Geneva, Switzerland. It is a specialized agency of the United Nations dedicated to developing a balanced international IP system.

Real Estate Rights relate to tangible property (land and buildings), not intellectual property. IPR covers intangible creations of the mind including patents, trademarks, copyrights, designs, and GIs.

India adopted its National IPR Policy in May 2016 with the vision "Creative India; Innovative India." DPIIT (Department for Promotion of Industry and Internal Trade) is the nodal agency.

The Paris Convention was adopted in 1883 and is one of the oldest international IP treaties. It establishes principles of national treatment and right of priority for industrial property.

The Berne Convention (1886) deals with the protection of literary and artistic works (copyrights). It establishes automatic protection without formalities and the principle of national treatment.

TRIPS Article 33 mandates that patent protection shall be available for a minimum of 20 years from the filing date. India complies with this under Section 53 of the Patents Act.

National Treatment (TRIPS Article 3) requires each WTO member to accord to nationals of other members treatment no less favorable than it accords to its own nationals regarding IP protection.

The Madrid Protocol provides a system for international registration of trademarks. India acceded to it in 2013, allowing trademark owners to file one application for protection in multiple countries.

The PCT allows inventors to file one international patent application that can then enter the national phase in multiple PCT member countries (currently 157 contracting states).

Section 3 of the Patents Act lists "what are not inventions" - categories excluded from patentability including discoveries, scientific theories, mathematical methods, business methods, computer programs per se, and more.

Section 3(d) excludes mere discovery of new forms, properties, or uses of known substances unless they result in enhancement of known efficacy. This is the famous "evergreening" prevention provision.

The three essential criteria for patentability under Section 2(1)(j) are: Novelty (new), Inventive Step (non-obvious), and Industrial Applicability (capable of being made or used in industry).

In Novartis v. Union of India (2013), the Supreme Court upheld rejection of patent for Glivec (cancer drug) under Section 3(d), ruling that the beta crystalline form did not show enhanced efficacy over the known substance.

Section 84 allows compulsory licensing after 3 years from grant if: (a) reasonable requirements not satisfied, (b) not available at reasonably affordable price, or (c) not worked in India.

India granted its first compulsory license in 2012 to Natco Pharma for Nexavar (Sorafenib Tosylate), a kidney and liver cancer drug patented by Bayer, due to unaffordable pricing and inadequate working.

Section 25(1) provides for pre-grant opposition by any person after publication but before grant. Section 25(2) is for post-grant opposition by any interested person within 1 year of grant.

Section 3(k) excludes "a computer programme per se" from patentability. However, computer programs with technical application or combined with hardware may be patentable if they produce a technical effect.

Under Section 53 of the Patents Act, the term of every patent is 20 years from the date of filing of the application, subject to payment of renewal fees.

Section 3(j) excludes plants and animals (other than micro-organisms), and essentially biological processes for production of plants/animals (other than non-biological and microbiological processes).

Section 9 deals with absolute grounds for refusal - marks that are devoid of distinctive character, descriptive, customary, deceptive, scandalous, or prohibited by law cannot be registered.

Section 11 deals with relative grounds for refusal - marks that are identical/similar to earlier marks, or conflict with prior rights like copyright, or would cause confusion cannot be registered.

Section 29 defines trademark infringement - use of identical/similar marks on identical/similar goods/services causing likelihood of confusion, or taking unfair advantage of well-known marks.

The classic trinity for passing off (from Reckitt & Colman v. Borden): Goodwill attached to plaintiff's goods/services, Misrepresentation by defendant, and Damage (or likelihood of damage) to plaintiff.

A well-known trademark is one known to a substantial segment of the public which uses such goods/services, such that use by another would be likely to be taken as indicating a connection.

Under Section 25, trademark registration is valid for 10 years from the date of application and can be renewed indefinitely for successive 10-year periods.

Under Section 2(1)(zb), a trademark includes shape of goods with distinctive character. However, shapes resulting from nature of goods, necessary for technical result, or giving substantial value are excluded under Section 9(3).

Dilution protects well-known marks against use on dissimilar goods/services that would take unfair advantage of or be detrimental to the distinctive character or repute of the mark (Section 29(4)).

Criminal liability under Sections 103-104 requires proving specific mens rea elements. Directors are not automatically liable - personal involvement must be established. Civil remedies (injunction, damages, delivery up) are available.

Section 12 permits registration of identical/similar marks for different proprietors in case of honest concurrent use or other special circumstances, with conditions/limitations as the Registrar deems fit.

Section 13 lists works in which copyright subsists: original literary, dramatic, musical and artistic works, cinematograph films, and sound recordings. The work must be original and fixed in a tangible medium.

Section 14 grants exclusive rights including reproduction, issuing copies, public performance, communication to public, translation, and adaptation. Copyright cannot control thoughts - only the expression of ideas in tangible form.

Section 17(c) provides that for works made in the course of employment under a contract of service, the employer is the first owner of copyright, unless there is an agreement to the contrary.

Under Section 22, copyright in literary, dramatic, musical, and artistic works subsists for the lifetime of the author plus 60 years from the beginning of the calendar year following the year of death.

Section 52(1)(a) permits fair dealing with a work for purposes of private or personal use including research, criticism, review, and reporting current events. The dealing must be "fair" considering the purpose, nature, and extent of use.

Section 57 provides for moral rights: (i) Right of paternity - to claim authorship, and (ii) Right of integrity - to restrain or claim damages for distortion, mutilation, or modification that would be prejudicial to honor or reputation.

Copyright in India arises automatically upon creation. Registration is voluntary but provides prima facie evidence of ownership in court proceedings. The Register of Copyrights maintained under Section 44 serves as documentary evidence.

Section 51 provides that copyright is infringed when any person without license from the owner does anything the exclusive right to do which is conferred on the owner, or permits a place to be used for infringing communication.

Section 31 allows the Copyright Board to grant compulsory license if the work is withheld from public, or the reasonable requirements of the public have not been satisfied, or the work is not available at a reasonable price.

The idea-expression dichotomy is a fundamental principle: copyright protects only the original expression of ideas, not the underlying ideas, facts, or concepts themselves. Ideas remain free for all to use.

India has no dedicated trade secrets legislation. Protection is derived from common law principles of breach of confidence, contract law (including NDAs), and equitable doctrines. Courts have recognized trade secrets as protectable.

Trade secret protection requires: (1) the information must be secret (not generally known), (2) it must have commercial value because of its secrecy, and (3) the owner must take reasonable steps to keep it secret.

NDAs are enforceable under the Indian Contract Act if they meet contract essentials: valid consideration, clear definition of confidential information, reasonable scope and duration, and must not be in restraint of trade under Section 27.

Misappropriation involves acquiring trade secrets through improper means (theft, bribery, breach of duty, espionage) or disclosure/use in breach of confidence. Independent discovery and legitimate reverse engineering are not misappropriation.

In Burlington Home Shopping v. Rajnish Chibber, the Delhi High Court recognized that confidential information and trade secrets are protectable in India under principles of equity and common law, even without specific legislation.

Garden leave clauses require departing employees to remain on payroll during notice period without working. This allows trade secrets and confidential information to become less current/valuable before they join competitors.

Reverse engineering is generally permitted if the product is lawfully obtained and there is no contractual restriction (like in license agreements). It is considered a legitimate means of discovering information not involving improper conduct.

Key difference: Patents require public disclosure for 20-year protection and protect against independent discovery. Trade secrets require maintained secrecy, can last indefinitely, but do not protect against independent discovery or reverse engineering.

Section 27 of the Indian Contract Act declares agreements in restraint of trade void. Post-employment non-compete clauses are generally unenforceable. However, confidentiality clauses protecting genuine trade secrets may be enforceable during and after employment.

Exit interviews serve to: remind departing employees of continuing confidentiality obligations, document return of company materials and data, identify what confidential information they accessed, and create evidence of the company's efforts to protect trade secrets.

An exclusive license grants rights to only one licensee in a defined territory/field, often excluding even the licensor. A non-exclusive license allows the licensor to grant similar licenses to multiple parties.

IP royalty structures include: Lump sum (one-time payment), Running royalties (per unit sold or percentage of revenue), Milestone payments (upon achieving targets), and combinations thereof.

Technology transfer agreements are comprehensive and typically include: IP licenses (patents, know-how, trade secrets), technical documentation, training of personnel, technical assistance, quality control provisions, and ongoing support.

Cross-licensing is an arrangement where two or more parties grant each other rights to use their respective IP. It is commonly used to resolve potential infringement disputes and enable use of complementary technologies.

A grant-back clause requires the licensee to grant the licensor rights (assignment or license) to improvements, modifications, or derivative works developed by the licensee. Competition authorities may scrutinize exclusive grant-backs.

FRAND (Fair, Reasonable, And Non-Discriminatory) licensing commitments apply to Standard Essential Patents (SEPs) - patents essential to implement industry standards (like 4G/5G), committed to standard-setting organizations.

Sub-licensing rights allow a licensee to grant licenses to third parties. These rights are not implied and must be expressly granted in the license agreement. The agreement should also specify terms, royalty sharing, and approval requirements.

Minimum guarantee royalty ensures the licensor receives a minimum payment regardless of the licensee's actual sales or performance. It protects against licensees who may not actively exploit the licensed IP.

Territory restrictions define the geographical area where the licensee can exercise the licensed IP rights. They are common and generally permissible, allowing licensors to grant different parties rights in different regions.

IP due diligence in M&A involves comprehensive review: verifying ownership chain, checking validity/enforceability, freedom-to-operate analysis, identifying encumbrances (licenses, security interests), pending disputes, and IP asset valuation.

The Commercial Courts Act, 2015 (as amended in 2018) specifies the value for commercial disputes at Rs. 3 lakhs. IP disputes are classified as commercial disputes under Section 2(1)(c)(xvii).

The three-factor test for interim injunction consists of: (1) Prima facie case, (2) Balance of convenience, and (3) Irreparable harm/injury. Proof of actual financial loss is not required at the interim stage.

Anton Piller orders (named after Anton Piller KG v. Manufacturing Processes Ltd.) are ex parte orders allowing search, inspection, and seizure of infringing materials to prevent destruction of evidence.

The Delhi High Court Intellectual Property Division (IPD) was established in July 2021 with dedicated benches for patent matters and other IP disputes, making it India's first specialized IP court.

Customs recordation enables IP right holders to record their rights with customs authorities, who can then suspend clearance of suspected infringing goods at the border for examination.

INDRP is administered by NIXI (National Internet Exchange of India) through designated arbitrators. It provides a dispute resolution mechanism for .IN domain names similar to UDRP for generic TLDs.

Expert evidence in patent cases is crucial for claim construction (interpreting patent claims), assessing technical equivalents, evaluating prior art, and determining whether alleged products/processes infringe the patent.

Wander Ltd. v. Antox India (1990) is a landmark Supreme Court decision establishing principles for granting interim injunctions in intellectual property cases, particularly the three-pronged test and appellate court's role.

John Doe/Ashok Kumar orders are granted against unknown defendants (often used in online piracy cases) allowing action against unidentified infringers. Delhi High Court pioneered such orders in Taj Television v. Rajan Mandal.

Mareva injunctions (named after Mareva Compania Naviera SA v. International Bulkcarriers SA) freeze defendant's assets to prevent their dissipation, ensuring that any damages awarded can be recovered.

The PCT national phase deadline is 30 months from priority date (31 months for some countries like India). This extended timeline allows applicants more time to assess commercial viability before incurring national filing costs.

The Paris Convention provides 12 months priority period for patents and utility models, and 6 months for trademarks and industrial designs, from the first filing date.

Central attack refers to the dependency of international registration on the basic mark for 5 years. If the basic application/registration is refused, withdrawn, or cancelled within this period, the international registration may also be cancelled.

The Hague System provides a mechanism for international registration of industrial designs. India acceded to the Hague Agreement in 2019, allowing designers to file for protection in multiple countries through one application.

TRIPS Part III requires members to provide civil and administrative procedures, provisional measures, border measures, and criminal procedures (for willful trademark counterfeiting and copyright piracy on commercial scale).

The Doha Declaration (2001) affirmed that TRIPS should be interpreted to support public health, confirmed members' right to use compulsory licensing, and led to the 2005 amendment allowing export of generic medicines to countries without manufacturing capacity.

International exhaustion means that once IP-protected goods are sold anywhere in the world by or with consent of the right holder, they can be freely resold globally. India follows international exhaustion for patents and trademarks.

Parallel imports are genuine goods (not counterfeits) imported from another country outside the authorized distribution channels. Their legality depends on the exhaustion doctrine followed by the importing country.

India is not a member of EPO. The EPO is a regional patent organization for European countries. Indian applicants must file separate applications in India and through EPO for European protection.

The WIPO Arbitration and Mediation Center offers ADR services including arbitration, mediation, and expert determination for IP and technology disputes. It also administers UDRP for domain name disputes.

In the DABUS cases, patent offices in US, UK, EPO, and India rejected listing AI as inventor. Courts held that under current law, only natural persons can be inventors. South Africa briefly granted such a patent but later withdrew it.

Section 3(d) is India's unique provision to prevent "evergreening" of pharmaceutical patents by refusing patents for mere new forms, derivatives, or uses of known substances unless they demonstrate significantly enhanced efficacy.

The GI Act, 1999 was enacted to comply with TRIPS obligations. It came into force in 2003. Darjeeling Tea was India's first registered GI in 2004-05.

Section 39 grants farmers the right to save, use, sow, resow, exchange, share, or sell their farm produce including seed of protected varieties, except selling branded seed. This is India's unique farmers' rights provision.

Section 6 of the Biological Diversity Act, 2002 requires prior approval from NBA before applying for any IP right (in or outside India) relating to any invention based on research or information on biological resources obtained from India.

TKDL documents India's traditional knowledge (Ayurveda, Unani, Siddha, Yoga) in patent-searchable format as prior art. It helps patent offices worldwide reject patents based on India's traditional knowledge (defensive protection).

Section 79 provides safe harbor protection to intermediaries, shielding them from liability for third-party content if they act as mere conduits and comply with due diligence requirements including takedown upon notice.

India does not grant data exclusivity for pharmaceutical test data. While TRIPS Article 39.3 requires protection of undisclosed test data, India interprets this as protection against unfair commercial use, not data exclusivity.

Biosimilars are regulated by CDSCO under the "Guidelines on Similar Biologics" (2016). Unlike generic drugs, biosimilars require comparative studies with reference biologics to demonstrate similarity in quality, safety, and efficacy.

Standard Essential Patents are patents essential to implementing a technical standard. Holders typically commit to license on FRAND (Fair, Reasonable and Non-Discriminatory) terms to enable industry adoption while receiving fair compensation.

Under Section 126 and Rule 109, a Patent Agent must be an Indian citizen, graduate in science/engineering/technology or law degree holder, and pass the Patent Agent Examination conducted by the Controller.

An IP audit comprehensively assesses all intellectual property assets including registered and unregistered rights, ownership chain, licensing arrangements, third-party IP usage, potential infringement risks, and IP-related agreements.

The three main IP valuation methods are: (1) Cost approach - based on development/replacement costs, (2) Market approach - based on comparable transactions, and (3) Income approach - based on future economic benefits. "Aesthetic approach" is not a recognized valuation method.

An FTO opinion (clearance search) analyzes whether making, using, or selling a product/process would infringe valid IP rights of third parties in a particular jurisdiction. It's distinct from patentability analysis.

IP watch services monitor trademark and patent databases to alert right holders about new applications that may conflict with their existing IP rights, enabling timely opposition or other protective action.

IP portfolio management involves strategic decisions about filing, maintaining, licensing, and abandoning IP rights based on business objectives, market relevance, competitive landscape, and cost-benefit analysis.

IP insurance covers costs associated with IP litigation - either defensive (costs of defending against infringement claims) or offensive/pursuit (costs of enforcing IP rights against infringers), including legal fees and damages.

IPR careers include Patent Agent/Attorney, Trademark Attorney, IP Counsel, IP Manager, Technology Transfer Officer, IP Analyst, and Licensing Executive. While CAs may work on IP valuation, it's not a primary IP career path.

Ethical obligations include client confidentiality, avoiding conflicts of interest, candor with IP offices (duty of disclosure), competent representation, and maintaining professional standards. Concealing prior art violates the duty of candor.

Startup IP strategy should identify core innovations, secure trademark/domain early, file provisional patents for key technology, maintain trade secrets properly, ensure IP assignment from founders/employees, and scale protection with business growth and funding.